Back to Search Start Over

Prevalence of current and past COVID-19 in Ohio adults.

Authors :
Turner AN
Kline D
Norris A
Phillips WG
Root E
Wakefield J
Li Z (Richard)
Lemeshow S
Spahnie M
Luff A
Chu Y
Francis MK
Gallo M
Chakraborty P
Lindstrom M
Lozanski G
Miller W
Clark S
Source :
Annals of epidemiology [Ann Epidemiol] 2022 Mar; Vol. 67, pp. 50-60. Date of Electronic Publication: 2021 Dec 16.
Publication Year :
2022

Abstract

Purpose To estimate the prevalence of current and past COVID-19 in Ohio adults. Methods We used stratified, probability-proportionate-to-size cluster sampling. During July 2020, we enrolled 727 randomly-sampled adult English- and Spanish-speaking participants through a household survey. Participants provided nasopharyngeal swabs and blood samples to detect current and past COVID-19. We used Bayesian latent class models with multilevel regression and poststratification to calculate the adjusted prevalence of current and past COVID-19. We accounted for the potential effects of non-ignorable non-response bias. Results The estimated statewide prevalence of current COVID-19 was 0.9% (95% credible interval: 0.1%-2.0%), corresponding to ∼85,000 prevalent infections (95% credible interval: 6,300-177,000) in Ohio adults during the study period. The estimated statewide prevalence of past COVID-19 was 1.3% (95% credible interval: 0.2%-2.7%), corresponding to ∼118,000 Ohio adults (95% credible interval: 22,000-240,000). Estimates did not change meaningfully due to non-response bias. Conclusions Total COVID-19 cases in Ohio in July 2020 were approximately 3.5 times as high as diagnosed cases. The lack of broad COVID-19 screening in the United States early in the pandemic resulted in a paucity of population-representative prevalence data, limiting the ability to measure the effects of statewide control efforts.<br /> (Copyright © 2021. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1873-2585
Volume :
67
Database :
MEDLINE
Journal :
Annals of epidemiology
Publication Type :
Academic Journal
Accession number :
34921991
Full Text :
https://doi.org/10.1016/j.annepidem.2021.11.009